The 5-year OS and DFS rates in the cancer cell-Tenascin-C-positive group (39.7% and 35.6%, respectively) were also significantly lower than those of the cancer cell-Tenascin-C-negative group (68.3% and 57.1%, respectively; OS: p = 0.001; DFS: p = 0.003). The gene discussed is TNC; the disease is cancer.